Market Tracker

09/30 4:09am ET

MannKind Corp (NASDAQ:MNKD)

0.5983
Delayed Data
As of Sep 29
 -0.0107 / -1.76%
Today’s Change
0.55
Today|||52-Week Range
3.79
-58.74%
Year-to-Date
Biotech Stocks Under $5: 2 to Buy, 1 to Avoid
Sep 24 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close0.61
Today’s open0.60
Day’s range0.59 - 0.62
Volume2,518,847
Average volume (3 months)3,762,526
Market cap$291.1M
Dividend yield--
Data as of 09/29/2016

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+74.73%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FOMXFoamix Pharmaceutica...+0.01+0.11%
CRHMCRH Medical Corp-0.10-2.51%
CRBPCorbus Pharmaceutica...-0.34-4.96%
OVASOvaScience Inc-0.61-7.78%
Data as of 09/29/2016

Financials

Next reporting dateOctober 31, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts